tradmap

AKTS Earnings Aktis Oncology, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Chart & overview → Latest filing

Quarterly results

Diluted EPS (quarterly)
-$22 -$11 $0 Q1 '25 Q2 '25 Q1 '26 Q2 '26
EPS
Revenue (quarterly)
$0 $2M $3M Q1 '25 Q2 '25 Q1 '26 Q2 '26
Revenue
Net income (quarterly)
-$24M -$12M $0 Q1 '25 Q2 '25 Q1 '26 Q2 '26
Net income

Reported EPS history

1–4 of 4
Q2 20262026-06-30-0.442026-08-1310-Q
Q1 20262026-03-31-0.382026-05-1110-Q
Q2 20252025-06-30-22.39——
Q1 20252025-03-31-18.60——

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.